Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.45 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.45 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.45 |
| ▸ | CETP | P11597 | 3/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | P2RY10 | O00398 | 3/20 | 0.41 |
| ▸ | GPR34 | Q9UPC5 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4946343 | 0.88 | CETP (0.48) | LPAR3LPAR1LPAR2CETPNPC1 | |
| SCHEMBL4948135 | 0.88 | CETP (0.48) | LPAR3LPAR1LPAR2CETPNPC1 | |
| SCHEMBL4948696 | 0.88 | CETP (0.48) | LPAR3LPAR1LPAR2CETPNPC1 | |
| SCHEMBL4948722 | 0.88 | CETP (0.48) | LPAR3LPAR1LPAR2CETPNPC1 | |
| SCHEMBL4948497 | 0.83 | CETP (0.44) | LPAR3LPAR1CETPNPC1RAB9A | |
| SCHEMBL28212839 | 0.81 | POLB (0.41) | LPAR3LPAR1LPAR2CETPNPC1 | |
| SCHEMBL8755061 | 0.81 | P2RY10 (0.49) | LPAR3LPAR1LPAR2CETPP2RY10 | |
| SCHEMBL27705486 | 0.80 | POLB (0.43) | CETP | |
| SCHEMBL28850802 | 0.77 | LPAR3 (0.44) | LPAR3LPAR1LPAR2CETPP2RY10 | |
| SCHEMBL28832283 | 0.77 | LPAR3 (0.44) | LPAR3LPAR1LPAR2CETPP2RY10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118591377-A | Antiviral prodrugs, intermediate and long acting formulations and methods | 加利福尼亚大学董事会 | 2024-09-03 | — | — | CN | disclosed |